TP53 and gastric cancer: Besides these, Xie et al. (2015) established a multi-index prediction model based on the six kinds of biomarkers (CEA, CA199, H.P., P53, PG I, and PG II), which was designed to achieve early screening and therapeutic evaluation of GC patients.